MYGN
Myriad Genetics Inc
Price:  
5.03 
USD
Volume:  
1,303,826.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYGN Relative Valuation

-394.1%
Upside

As of 2025-06-16, the Relative Valuation of Myriad Genetics Inc (MYGN) is (14.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.03 USD, the upside of Myriad Genetics Inc based on Relative Valuation is -394.1%.

The range of the Relative Valuation is (11.37) - (16.19) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.3x - 18.4x 14.3x
Forward P/E multiples 9.9x - 14.7x 12.6x
Fair Price (11.37) - (16.19) (14.80)
Upside -326.1% - -421.9% -394.1%
5.03 USD
Stock Price
(14.80) USD
Fair Price

MYGN Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 -4.57
2025-06-12 -4.72
2025-06-11 -4.71
2025-06-10 -4.75
2025-06-09 -4.72
2025-06-06 -4.63
2025-06-05 -4.47
2025-06-04 -4.81
2025-06-03 -4.44
2025-06-02 -4.05
2025-05-30 -3.81
2025-05-29 -3.78
2025-05-28 -3.94
2025-05-27 -3.77
2025-05-23 -3.55
2025-05-22 -3.57
2025-05-21 -3.70
2025-05-20 -4.05
2025-05-19 -4.03
2025-05-16 -3.75
2025-05-15 -3.74
2025-05-14 -3.49
2025-05-13 -3.74
2025-05-12 -3.86
2025-05-09 -3.54
2025-05-08 -3.66
2025-05-07 -3.88
2025-05-06 -6.61
2025-05-05 -7.00
2025-05-02 -6.87
2025-05-01 -6.48
2025-04-30 -6.74
2025-04-29 -6.55
2025-04-28 -6.82
2025-04-25 -6.75
2025-04-24 -6.70
2025-04-23 -6.63
2025-04-22 -6.75
2025-04-21 -6.73
2025-04-17 -6.95
2025-04-16 -7.19
2025-04-15 -7.28
2025-04-14 -7.35
2025-04-11 -7.27
2025-04-10 -7.23
2025-04-09 -7.68
2025-04-08 -7.03
2025-04-07 -7.34
2025-04-04 -7.39
2025-04-03 -7.65